Biologics for arthritis may reduce patients' CV risk
The therapy's benefit might be due to its anti-inflammatory properties, study suggests
21st August 2018
By Clare Pain
Patients taking biologics for inflammatory arthritis may have a reduced risk of cardiovascular events compared with those who are biologic-naive.